Biogen DSO Ratio 2011-2026 | BIIB

Annual DSO Ratio Biogen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
50.7	57.9	62.5	58.4	57.6	51.5	62.7	67.4	69	55.5	52.3	59.3	56.7	63.2	58.8

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
69	50.7	58.9

Quarterly DSO Ratio Biogen

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	61.9	-	57	56.4	57.3	-	56	53.2	28.9	61.2	51.7	47.4	49	46.7	47.7	47.5	50.2	50.7	52	53.2	54.6	49.3	53	53	52.4	45.8	44.5	45.5	44.6	39.4	40.3	43.2	45	44.7	47	48.7	45.4	38.3	41.2	43.6	48.7	44.2	45.2	44.1	44.9	40.2	40.7	44.1	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
61.9	28.9	47.8

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Precigen PGEN	91.2	$ 3.1	-0.96 %	$ 758 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Ascendis Pharma A/S ASND	132	$ 220.9	2.49 %	$ 5 B	Danmark
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 19.57	1.77 %	$ 915 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Arbutus Biopharma Corporation ABUS	50	$ 4.53	5.1 %	$ 868 M	Canada
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
CytomX Therapeutics CTMX	12.3	$ 4.22	-0.47 %	$ 582 M	USA
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Cyclacel Pharmaceuticals CYCC	81.5 K	-	-5.98 %	$ 34.1 M	USA